Ventana Medical Systems Inc:企業のM&A・提携動向(医療機器分野)

GlobalDataが発行した調査報告書(GDME1019D)
◆英語タイトル:Ventana Medical Systems Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME1019D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年1月25日
◆ページ数:36
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd which manufactures and commercializes the tissue-based diagnostic solutions for healthcare market. It develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pathology, dermatopathology, hematopathology and prostate pathology. The company offers detection systems such as ultraVIEW SISH Detection Kit, ISH iVIEW Blue Plus detection kit, ultraView Red ISH DIG detection kit and ultraView SISH DNP detection kit.VMS also offers technical and application support services. The company markets its products through its channel of network distributors. VMS is headquartered in Tucson, Arizona, the US.

Ventana Medical Systems Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ventana Medical Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Ventana Medical Systems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Ventana Medical Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Ventana Medical Systems Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Ventana Medical Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ventana Medical Systems Inc, Medical Equipment, Deal Details 11
Partnerships 11
Ventana Medical Systems Enters Into Licensing Agreement With Biocare Medical 11
Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E 12
Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker 13
Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology 13
Research Ventures & Licensing Enters Into Licensing Agreement With Ventana Medical Systems 14
Cell Signaling Technology Enters Into Licensing Agreement With Ventana Medical Systems 15
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 16
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems 17
Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 18
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 18
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test 19
Ventana Medical Enters into Co-Development Agreement with MedImmune 20
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab 21
Ventana Extends Co-Development Agreement With Bayer Pharma 22
Ventana Medical Systems Enters Into Co-Development Agreement With Incyte For Companion Diagnostic Tests 22
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests 23
Ventana Medical Systems And TGen Enter Into Agreement To Develop Cancer Diagnostic Markers 24
Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform 25
Seattle Genetics And Millennium Pharma Enter Into Co-Development Agreement With Ventana Medical Systems 26
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma 27
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 28
Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems 29
AEterna Zentaris Enters Into Co-Development Agreement With Ventana Medical Systems 30
Ventana Medical Systems Inc – Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Product News 35
Feb 22, 2016: FDA-approved ALK IHC CDx superior to another IHC assay for patient selection 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Ventana Medical Systems Inc, Medical Equipment, Key Facts 1
Ventana Medical Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Ventana Medical Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Ventana Medical Systems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Ventana Medical Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Ventana Medical Systems Inc, Deals By Market, 2011 to YTD 2017 8
Ventana Medical Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ventana Medical Systems Enters Into Licensing Agreement With Biocare Medical 11
Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E 12
Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker 13
Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology 13
Research Ventures & Licensing Enters Into Licensing Agreement With Ventana Medical Systems 14
Cell Signaling Technology Enters Into Licensing Agreement With Ventana Medical Systems 15
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 16
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems 17
Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 18
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 18
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test 19
Ventana Medical Enters into Co-Development Agreement with MedImmune 20
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab 21
Ventana Extends Co-Development Agreement With Bayer Pharma 22
Ventana Medical Systems Enters Into Co-Development Agreement With Incyte For Companion Diagnostic Tests 22
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests 23
Ventana Medical Systems And TGen Enter Into Agreement To Develop Cancer Diagnostic Markers 24
Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform 25
Seattle Genetics And Millennium Pharma Enter Into Co-Development Agreement With Ventana Medical Systems 26
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma 27
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 28
Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems 29
AEterna Zentaris Enters Into Co-Development Agreement With Ventana Medical Systems 30
Ventana Medical Systems Inc, Key Competitors 32
Ventana Medical Systems Inc, Key Employees 33
Ventana Medical Systems Inc, Subsidiaries 34

List of Figures
Ventana Medical Systems Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Ventana Medical Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Ventana Medical Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Ventana Medical Systems Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Ventana Medical Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Ventana Medical Systems Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Ventana Medical Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Ventana Medical Systems Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Ventana Medical Systems Inc:企業のM&A・提携動向(医療機器分野)(Ventana Medical Systems Inc - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆